Detalhe da pesquisa
1.
A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
J Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655842
2.
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
Clin Infect Dis
; 64(5): 614-620, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986684
3.
An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate.
AIDS Res Hum Retroviruses
; 38(4): 279-287, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541872
4.
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
AIDS Res Hum Retroviruses
; 38(4): 257-268, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498980
5.
Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).
AIDS Educ Prev
; 33(5): 361-376, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596427
6.
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
PLoS One
; 12(7): e0181607, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750059
7.
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
PLoS One
; 5(2): e9310, 2010 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20174579